| Pharmaceutical active ingredients: |
| Isoetharine Hydrochloride |
| Available forms, composition and doses of Bronkosol: |
| Solution; Inhalation; Isoetharine Hydrochloride 0.25%Solution; Inhalation; Isoetharine Hydrochloride 1% |
| Bronkosol medical category: |
| Human:Beta2-adrenergic receptors agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AC07 - IsoetarineR03CC06 - Isoetarine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Etyprenaline | Isoetharine | Unidentified Pharmaceutical Company |
| Neoisuprel | Isoetharine | Unidentified Pharmaceutical Company |
| Arm-A Med Isoetharine | Isoetharine Hydrochloride | Unidentified Pharmaceutical Company |
| Asthmalitan | Isoetharine Hydrochloride | 3M |
| Beta-2 | Isoetharine Hydrochloride | Nephron Pharmaceuticals |
| Isoetharine | Isoetharine Hydrochloride | AstraZeneca |
| Isoetharine | Isoetharine Hydrochloride | Baxter |
| Isoetharine | Isoetharine Hydrochloride | DEY Laboratories |
| Isoetharine | Isoetharine Hydrochloride | International Medication Systems |
| Isoetharine | Isoetharine Hydrochloride | Parke-Davis |